USPTO Examiner DANIEL ANTARIUS S - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
16973976Device for Administering a Medicinal Liquid by InjectionDecember 2020November 2024Allow4740NoNo
16973467A PUMP ARRANGEMENT, CONFIGURED TO BE USED WITH A DOUBLE BREAST PUMP DEVICEDecember 2020April 2024Allow4000NoNo
17114788CATHETER WITH TEXTURED SURFACEDecember 2020June 2023Allow3010NoNo
17109600SINGLE-SITE INSERTION OF MULTIPLE MEDICAL DEVICESDecember 2020June 2023Allow3120YesNo
17109082DRUG INFUSION SETDecember 2020December 2023Abandon3740NoNo
17057728DRUG DELIVERY DEVICE WITH NEEDLE ACTUATION MECHANISMNovember 2020April 2023Allow2900NoNo
16951819INTRODUCER NEEDLE WITH NOTCHES FOR IMPROVED FLASHBACKNovember 2020January 2023Allow2610YesNo
16951893ROTATIONALLY BIASED INSERTION MECHANISM FOR A DRUG DELIVERY PUMPNovember 2020January 2023Allow2660YesNo
17093136SYSTEMS AND METHODS FOR ANCHORING MEDICAL DEVICESNovember 2020October 2023Allow3510NoNo
17093004Medical and Dental Safety SyringeNovember 2020August 2022Abandon2110NoNo
17062426AMBULATORY MEDICAMENT DEVICE WITH AUTOMATIC RESUMPTION OF MEDICAMENT DELIVERYOctober 2020December 2021Abandon1520YesNo
16948638REFILL AND DOSAGE MANAGEMENT DEVICES AND ASSOCIATED SYSTEMS AND METHODS FOR USE WITH COMPUTERIZED ORAL PRESCRIPTION ADMINISTRATION DEVICESSeptember 2020December 2024Allow5160YesNo
16981994MEDICAMENT CONTAINER HOLDERSeptember 2020December 2024Allow5130NoNo
17017835ELASTOMERIC STRAIN RELIEF LAYERING FOR CATHETERSSeptember 2020November 2024Allow5030YesNo
17003278CHEMICAL FLUID INJECTION DEVICEAugust 2020December 2024Abandon5240NoNo
17001553NEEDLE ARRAY DEVICEAugust 2020December 2024Abandon5250YesNo
16989293CATHETER SYSTEM WITH EXTENDABLE EXTENSION TUBEAugust 2020February 2023Allow3030YesNo
16963927APPARATUS AND METHOD FOR INJECTING MATERIAL INTO ORGANIC TISSUEJuly 2020September 2024Allow5040NoNo
16894334CLOSED SYSTEM CATHETERJune 2020April 2025Allow5820YesYes
16892082MEDICATION FLUID INFUSION SET COMPONENT WITH INTEGRATED PHYSIOLOGICAL ANALYTE SENSOR, AND CORRESPONDING FLUID INFUSION DEVICEJune 2020November 2022Allow3000NoNo
16884832VERY HIGH VOLUME USER FILLED DRUG DELIVERY DEVICEMay 2020September 2021Allow1610NoNo
16879589SYRINGE SUITABLE FOR HYDROGEN PEROXIDE SOLUTION AND KIT THEREOFMay 2020November 2021Abandon1830YesNo
16762198METHOD AND DEVICE FOR THE NEEDLE-FREE INJECTING OF FLUID INTO A SUBSTRATEMay 2020August 2024Allow5140YesNo
16762189METHOD AND DEVICE FOR THE NEEDLE-FREE INJECTING OF FLUID INTO A SUBSTRATE, AND FLUID CONTAINER FOR USE IN THE METHOD AND THE DEVICEMay 2020May 2023Abandon3610NoNo
16759274INJECTION DEVICEApril 2020April 2023Allow3530YesNo
16830828CATHETER PORTMarch 2020June 2023Abandon3830YesNo
16817835FLUID COLLECTORMarch 2020June 2021Allow1500NoNo
16793120INTRAVASCULAR DELIVERY SYSTEM AND METHOD FOR PERCUTANEOUS CORONARY INTERVENTIONFebruary 2020February 2023Allow3630YesNo
16725704INTRODUCER NEEDLE WITH NOTCHES FOR IMPROVED FLASHBACKDecember 2019January 2022Allow2510NoNo
16708075TUBING MARKERSDecember 2019June 2023Abandon4340NoNo
16613703MEDICAL DEVICE WITH RESILIENTLY RETRACTING SAFETY NEEDLENovember 2019November 2020Allow1210YesNo
16682849SAFETY DEVICE FOR RETRACTION OF A NEEDLE AND GUIDEWIRE FOR MEDICAL PROCEDURES AND METHOD OF USENovember 2019March 2022Allow2811NoNo
16594323TRACHEOSTOMY TUBE HOLDER ATTACHMENTOctober 2019June 2023Abandon4420YesNo
16572384SYRINGE CONTROL ASSEMBLYSeptember 2019May 2025Allow6060NoNo
16558871CATHETER PRIMING DEVICES, SYSTEMS AND METHODSSeptember 2019March 2023Allow4211YesNo
16539032HOSE CADDYAugust 2019April 2024Abandon5630NoNo
16530167CATHETER DELIVERY DEVICEAugust 2019September 2021Allow2610YesNo
16439993MANIFOLDS, SYSTEMS, AND METHODS FOR ADMINISTERING REDUCED PRESSURE TO A SUBCUTANEOUS TISSUE SITEJune 2019February 2023Abandon4401NoNo
16343585WARMING DEVICE AND INFUSION SYSTEMApril 2019November 2022Allow4321YesNo
16376894SYSTEMS AND METHODS FOR TOPICAL APPLICATION OF MOLECULAR HYDROGENApril 2019October 2023Allow5431NoNo
16338797PATIENT TRAINING DEVICE FOR USE WITH A SAFETY SYRINGE INJECTORApril 2019November 2022Allow4310NoNo
16366999DRUG SOLUTION ADMINISTRATION DEVICE AND METHOD FOR CONTROLLING DRUG SOLUTION ADMINISTRATION DEVICEMarch 2019September 2022Allow4230YesNo
16366724ASSEMBLY FOR SYRINGE, PREFILLED SYRINGE, SEAL CAP FOR PIERCING NEEDLE-ATTACHED BARREL, AND PACKAGE FOR ASSEMBLY FOR SYRINGEMarch 2019May 2022Abandon3820YesNo
16356972Systems and Methods for Treating the Nasal CavityMarch 2019October 2023Abandon5551YesNo
16298003STEERABLE SHEATH FOR INTRAVASCULAR MEDICAL DEVICESMarch 2019October 2021Abandon3110NoNo
16298175VASCULAR ACCESS SITE MANAGEMENT SYSTEMMarch 2019April 2023Abandon4931NoNo
16293957MEDICAL NEEDLEMarch 2019March 2022Allow3630YesNo
16280899CATHETER ASSEMBLYFebruary 2019March 2023Allow4941YesNo
16269249Portable Devices And Methods For Detecting, Identifying And Quantifying Amounts Of Subcutaneously Injected CompoundsFebruary 2019December 2021Abandon3411NoNo
16256543URINARY BLADDER IRRIGATION DEVICE AND METHOD FOR USING THE SAMEJanuary 2019February 2021Allow2510NoNo
16320048SELF-HEATED INTRAVENOUS APPARATUSJanuary 2019September 2022Abandon4330NoNo
16249542SYSTEMS AND METHODS FOR ROBOTIC INFECTION TREATMENT OF A PROSTHESISJanuary 2019March 2023Allow5041YesYes
16242588MEDICAL SPACER FOR MANAGING IV LINESJanuary 2019July 2021Abandon3020YesNo
16312223Safety Mechanism for a Push-Off Cap of a Medicament Delivery DeviceDecember 2018July 2020Allow1900NoNo
16309206An Apparatus Configured to Enable a Flow of Current Through a User's SkinDecember 2018September 2022Abandon4640YesNo
16218324MAGNETIC DOSAGE SENSINGDecember 2018March 2022Abandon3930YesNo
16204596HEMOSTASIS VALVE SYSTEMS AND ASSOCIATED METHODSNovember 2018March 2025Abandon6071YesNo
16305210DOSING APPARATUS AND INJECTION DEVICENovember 2018July 2021Allow3230YesNo
16302224IMPROVED FLUID LINE CONNECTOR DEVICENovember 2018April 2023Abandon5341YesNo
16171566WOUND DRESSINGS AND SYSTEMS FOR EFFLUENT MANAGEMENT OF TOPICAL WOUND THERAPY AND RELATED METHODSOctober 2018July 2021Allow3311NoNo
16171774SMALL VOLUME TISSUE PROCESSING DEVICESOctober 2018December 2021Abandon3830YesNo
16136798Medical Component Securement DeviceSeptember 2018March 2021Abandon3020NoNo
16136901Medical and Dental Safety SyringeSeptember 2018December 2020Abandon2710NoNo
16137016BALLOON CATHETER, METHOD OF MANUFACTURING A BALLOON CATHETER, AND TREATMENT METHODSeptember 2018March 2023Allow5441YesYes
16132878INTRAVASCULAR DELIVERY SYSTEM AND METHOD FOR PERCUTANEOUS CORONARY INTERVENTIONSeptember 2018June 2021Abandon3381YesNo
16085274STAGED TELESCOPIC SCREW ASSEMBLY HAVING DIFFERENT VISUAL INDICATORSSeptember 2018August 2021Allow3540YesNo
16117999MICRO NEEDLEAugust 2018December 2020Abandon2710NoNo
16103514NEEDLELESS INJECTION DEVICE WITH A CURVED MEMBRANEAugust 2018May 2023Allow5730YesNo
16077343COMPACT PLATFORM FOR ACCURATE DRUG DELIVERYAugust 2018January 2021Abandon2910NoNo
16049093GARMENT SYSTEM PROVIDING BIOMETRIC MONITORING FOR MEDICAL CONDITION ASSESSMENTJuly 2018October 2022Allow5141YesNo
16049023Health Care Safety DevicesJuly 2018November 2020Abandon2810NoNo
16040345DOSAGE MEASUREMENT SYSTEM IN A PEN BUTTONJuly 2018January 2022Abandon4231NoNo
16040353STRAIN BASED DOSAGE MEASUREMENTJuly 2018April 2024Abandon6071NoNo
16071250DOCKING STATION FOR AN ENTERAL FEEDING DEVICEJuly 2018May 2022Allow4631YesNo
16066927TREATMENT DEVICE AND METHOD FOR CONTROLLING SAMEJune 2018May 2021Allow3530YesNo
16066969MECHANISM FOR SEQUENTIAL DOSE DELIVERYJune 2018May 2022Allow4740NoNo
16061228METHODS AND FORMULATIONS FOR TREATING VASCULAR DISEASEJune 2018January 2024Abandon6021YesYes
16001498REFILL AND DOSAGE MANAGEMENT DEVICES AND ASSOCIATED SYSTEMS AND METHODS FOR USE WITH COMPUTERIZED ORAL PRESCRIPTION ADMINISTRATION DEVICESJune 2018June 2020Allow2410NoNo
15782021GEOMETRIC CONFIGURATIONS FOR GASTRIC RESIDENCE SYSTEMSJune 2018September 2023Allow6051YesNo
15779033AN INJECTION DEVICEMay 2018April 2021Allow3521YesNo
15778501A DRUG DELIVERY DEVICE WITH A CAPMay 2018September 2020Allow2710NoNo
15778263MEDICAMENT INJECTION DEVICEMay 2018June 2022Allow4950YesNo
15778348MEDICAMENT DELIVERY DEVICEMay 2018January 2021Allow3220NoNo
15777284MICROPUMPMay 2018June 2023Allow6061YesNo
15777482MEDICAL INFUSION PUMPS AND SYSTEMSMay 2018May 2021Abandon3620NoNo
15982897APPLICATORMay 2018January 2022Abandon4441NoNo
15776418PRE-FILLED PLASTIC SYRINGE CONTAINING A VEGF ANTAGONISTMay 2018July 2022Abandon5050YesNo
15776535FEMALE CONNECTORMay 2018February 2022Abandon4541NoNo
15776671MULTI-WAY VALVE WITH MULTIPLE RETENTION RINGMay 2018July 2021Abandon3840YesNo
15966766CATHETER SECURING WRAPApril 2018September 2020Abandon2810NoNo
15769592CATHETERS FOR DEBONDING FOULING AGENTS FROM AN INTERIOR SURFACE THEREOF AND RELATED METHODSApril 2018December 2021Abandon4440NoNo
15766581DRUG DELIVERY DEVICE WITH SLIM DRIVE MECHANISMApril 2018June 2022Allow5050NoYes
15766608INJECTION DEVICEApril 2018April 2020Allow2410NoNo
15946593INTRODUCER NEEDLE WITH NOTCHES FOR IMPROVED FLASHBACKApril 2018August 2020Allow2810NoNo
15942617GASTROINTESTINAL TRACT CONSTRICTING METHODApril 2018December 2020Allow3230YesNo
15942961HOLLOW NEEDLE AND PIVOTABLE HUB SYSTEMApril 2018October 2021Allow4230YesNo
15941801DEVICE FOR TREATING VENOUS INCOMPETENCE, AND RELATED METHODSMarch 2018November 2020Abandon3110NoNo
15939976IMPLANTABLE ACCESS DEVICE FOR ACCESSING THE VASCULAR SYSTEM OF A HUMAN OR ANIMAL BODYMarch 2018October 2020Allow3120YesNo
15764372PISTON WASHER ASSEMBLY, METHOD OF ASSEMBLY AND DRUG DELIVERY DEVICE INCORPORATING SUCH PISTON WASHER ASSEMBLYMarch 2018October 2022Abandon5541NoNo
15764670ELECTROLYTE ADJUSTMENT INFUSION SYSTEM AND METHODMarch 2018August 2020Abandon2810NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner DANIEL, ANTARIUS S.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
1
(50.0%)
Examiner Reversed
1
(50.0%)
Reversal Percentile
79.5%
Higher than average

What This Means

With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
9
Allowed After Appeal Filing
3
(33.3%)
Not Allowed After Appeal Filing
6
(66.7%)
Filing Benefit Percentile
56.0%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner DANIEL, ANTARIUS S - Prosecution Strategy Guide

Executive Summary

Examiner DANIEL, ANTARIUS S works in Art Unit 3783 and has examined 128 patent applications in our dataset. With an allowance rate of 53.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 36 months.

Allowance Patterns

Examiner DANIEL, ANTARIUS S's allowance rate of 53.9% places them in the 16% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by DANIEL, ANTARIUS S receive 2.67 office actions before reaching final disposition. This places the examiner in the 74% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by DANIEL, ANTARIUS S is 36 months. This places the examiner in the 38% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +18.9% benefit to allowance rate for applications examined by DANIEL, ANTARIUS S. This interview benefit is in the 60% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 18.4% of applications are subsequently allowed. This success rate is in the 20% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 12.8% of cases where such amendments are filed. This entry rate is in the 15% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 100% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 71.4% of appeals filed. This is in the 60% percentile among all examiners. Of these withdrawals, 80.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 75.0% are granted (fully or in part). This grant rate is in the 80% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.